1. Pink Sheet
  2. >>Agency Leadership
  3. >>US FDA

Moscicki, One Of US FDA's Industry Connections, Moves To PhRMA

 
• By Derrick Gingery

One of the faces of FDA's effort to recruit senior leaders from outside its walls has decided to return to industry.

FDA entrance sign 2016
Moscicki spearheaded an unofficial campaign to recruit senior industry officials to FDA.

Richard Moscicki, who had been deputy director for science operations in the Center for Drug Evaluation and Research, will become chief medical officer and executive vice president at the Pharmaceutical Research and Manufacturers of America (PhRMA), where he will lead the trade group's science and regulatory advocacy efforts. PhRMA said in an Aug. 30 statement that Moscicki is expected to begin in early October.

In a statement from PhRMA, Moscicki said he was pleased to join the organization at a time when the regulatory environment for burgeoning new treatments in

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from US FDA

More from Agency Leadership

EMA Explores Using AI Language Models To Refine Oncology Guidance

 
• By Vibha Sharma

The European Medicines Agency has for the first time explicitly stated it is considering the use of large language models as a tool to improve the readability of a scientific guideline.

Pink Sheet Podcast: A New Director For US FDA’s Biologics Center, Guidance Production Slowdowns

 
• By Derrick Gingery, Sue Sutter, and Nielsen Hobbs

Pink Sheet editors discuss the appointment of Vinay Prasad as the new director of the Center for Biologics Evaluation and Research and revelations that FDA layoffs now are hindering development of guidance documents.

US FDA Restoring Some Library Resources

 
• By Sue Sutter and Derrick Gingery

Agency staff once again have access to the Lexis-Nexis legal and news database, but are still waiting for access to journals, and laid off librarians have not been reinstated.